2440087-54-5
Chemical Structure
ERX-41
- CAS No.: 2440087-54-5
- Formula:C38H48N4O9
- Molecular Weight:704.81
IUPAC Name: 3-(2-hydroxyethoxy)-N-(2-isobutoxy-4-((2-isobutoxy-4-(((1r,4r)-4-methylcyclohexyl)carbamoyl)phenyl)carbamoyl)phenyl)-4-nitrobenzamide
InChIKey: QOYORXKDWMJNHD-UAHYGDRYSA-N
SMILES: O=C(C1=CC(OCCO)=C(C=C1)[N+]([O-])=O)NC2=C(C=C(C=C2)C(NC3=C(C=C(C=C3)C(N[C@H]4CC[C@@H](CC4)C)=O)OCC(C)C)=O)OCC(C)C
Biological Activity: ERX-41 is an orally active and stereospecific small molecule targeting to lysosomal acid lipase A (LIPA). ERX-41 induces endoplasmic reticulum (ER) stress resulting in cell death, indicating a function independent of LIPA but dependent on its ER localization. ERX-41 involves in a targeted strategy for solid tumors[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ERX-41 | 98.25% | ERX-41 is an orally active and stereospecific small molecule targeting to lysosomal acid lipase A (LIPA). ERX-41 induces endoplasmic reticulum (ER) stress resulting in cell death, indicating a function independent of LIPA but dependent on its ER localization. ERX-41 involves in a targeted strategy for solid tumors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
